Inherited genetics can influence safety and success of CAR-T cell therapy News-Medical.Net 20:15 Fri, 24 Jul
Hyundai Hope on Wheels Awards $100,000 to Roswell Park to Fund CAR T-Cell Research for Children with AML Newswise (Press Release) 22:03 Thu, 23 Jul
CD8+ T-Cell Count Predicts Prognosis in DLBCL Utilizing R-CHOP Rare Disease Advisor 18:46 Thu, 23 Jul
MEK inhibition could limit T cell exhaustion and give a boost to immunotherapy News-Medical.Net 18:40 Thu, 23 Jul
Eurofins Viracor Launches Bkv inSIGHT™ T-Cell Immunity Panel to Support BK Virus Immune Monitoring in Kidney Transplant Patients PR Newswire (Press Release) 16:02 Wed, 22 Jul
Car T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight PR Newswire (Press Release) 15:32 Wed, 22 Jul
Tikva Allocell Closes $8 Million Series A Financing to Advance Engineered Ebv-Specific T-Cell Therapy for Solid Tumors PR Newswire (Press Release) 12:04 Wed, 22 Jul
New bispecific T cell engager platform targets ovarian cancer in preclinical studies Drug Target Review 10:15 Wed, 22 Jul
Wistar scientists develop new bispecific T cell engager to target ovarian cancer News-Medical.Net 21:38 Tue, 21 Jul
Nektar Therapeutics Announces Start of Phase 3 zenith ad Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis PR Newswire (Press Release) 12:00 Tue, 21 Jul
Weekly reads: T cell stem cells, thymus as anti-aging organ, octopus ribosomes, longevity ethics The Niche (Weblog) 09:43 Sun, 19 Jul
San Antonio hospital sees CAR T-cell therapy surge for cancer patients. Researchers are trying to find out if it could it be used to treat MS and lupus. San Antonio Report 15:13 Sat, 18 Jul
Trial Planned to Evaluate Dual-Targeting CAR T-Cell Candidate in MG and MS Rare Disease Advisor 20:07 Fri, 17 Jul
Researchers uncover new T cell attack mechanism against acute myeloid leukemia News-Medical.Net 04:00 Thu, 16 Jul
Anova and Nouveau Biosciences Announce Partnership to Deliver Clinical Trials of Kromastat for the Treatment of Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphoma Business Wire (Press Release) 17:06 Wed, 15 Jul
A targetable micropeptide reprograms macrophages to suppress T cell anti-tumor immunity Nature.com 12:24 Wed, 15 Jul
New Combination T-Cell Therapy Reduces Chronic GVHD Risk in ALL Rare Disease Advisor 01:04 Tue, 14 Jul
SL Science seeks US orphan drug designation for γδ T-cell therapy BioWorld 15:50 Mon, 13 Jul Article paywall
Outpatient Monitoring of CAR T-Cell Therapy Reduces Hospitalization, With No Impact on Mortality Oncology Nurse Advisor 15:25 Fri, 10 Jul
Gleneagles Hospital helps brain cancer patient to recover through indigenous car-T cell therapy The Hindu 20:30 Wed, 08 Jul Article paywall
Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf car-T Therapies for T-Cell Cancers Business Wire (Press Release) 14:02 Wed, 08 Jul
Dupixent and Cutaneous T-Cell Lymphoma: What Patients Should Know About the Growing Litigation JD Supra 02:05 Tue, 07 Jul
New Combination T-Cell Therapy Reduces Chronic GVHD Risk in MDS Rare Disease Advisor 22:10 Mon, 06 Jul
Montreal teen first minor in Quebec to receive car-T cell therapy for cancer treatment CTV News Montreal 20:27 Sat, 04 Jul
LucasBio and Institut Pasteur Korea co-develop memory T-cell therapy candidate for SFTS Korea Biomedical Review 06:41 Fri, 03 Jul
First-in-class experimental CAR T-cell therapy shows promise against solid tumors News-Medical.Net 03:33 Fri, 03 Jul
Orca Dives Into Commercial Waters With FDA Approval For T-Cell Therapy Tregzi Scrip Pharma Intelligence 08:02 Thu, 02 Jul
Orca’s T-cell therapy approach to Hsct wins FDA nod as Tregzi BioWorld 21:59 Wed, 01 Jul Article paywall
LEF1 and niche-derived factors regulate T cell stemness across chronic diseases News-Medical.Net 19:52 Wed, 01 Jul
CAR-T cell therapy shows potential to eliminate aggressive glioblastoma News-Medical.Net 18:40 Wed, 01 Jul
Identification of cross-stage, cross-species malaria CD8+ T cell antigens Nature.com 16:59 Wed, 01 Jul
Pre-existing antibody and T cell responses to SaCas9, AsCas12a and CasΦ are comparable in naïve individuals Nature.com 10:00 Wed, 01 Jul
